PWR
50
-20
COF
65
-2
CVS
33
-2
XRX
41
-18
STX
73
-5
TJX
65
-4
CMCSA
55
2
WFC
74
-16
FRT
62
4
WU
47
-18
XEL
39
-30
PM
49
-25
ZBH
44
-25
MUR
38
5
KEY
74
2
NKE
40
-3
NVDA
46
-4
ORCL
24
-4
XOM
48
-17
BIIB
48
2
PWR
50
-20
COF
65
-2
CVS
33
-2
XRX
41
-18
STX
73
-5
TJX
65
-4
CMCSA
55
2
WFC
74
-16
FRT
62
4
WU
47
-18
XEL
39
-30
PM
49
-25
ZBH
44
-25
MUR
38
5
KEY
74
2
NKE
40
-3
NVDA
46
-4
ORCL
24
-4
XOM
48
-17
BIIB
48
2
Financhill
Back

Calvert US Mid-Cap Core Responsible Index ETF Vs. Rigel Pharmaceuticals, Inc. Industry Stock Comparison

Sell
47

CVMC
Calvert US Mid-Cap Core Responsible Index ETF

Last Price:
$65.00
Seasonality Move:
2.92%
Buy
72

RIGL
Rigel Pharmaceuticals, Inc.

Last Price:
$42.22
Seasonality Move:
-1.35%
Sell
47
Calvert US Mid-Cap Core Responsible Index ETF (CVMC) is a Sell

Is Calvert US Mid-Cap Core Responsible Index ETF a Buy, Sell or Hold?

  • The current Calvert US Mid-Cap Core Responsible Index ETF [CVMC] share price is $64.31. The Score for CVMC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • CVMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Rigel Pharmaceuticals, Inc. (RIGL) is a Buy

Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $41.94. The Score for RIGL is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CVMC Stock Price Chart

What is Calvert US Mid-Cap Core Responsible Index ETF's stock price today?

  • The Calvert US Mid-Cap Core Responsible Index ETF share price today is $64.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVMC is experiencing selling pressure, which indicates risk of future bearish movement.

RIGL Stock Price Chart

What is Rigel Pharmaceuticals, Inc.'s stock price today?

  • The Rigel Pharmaceuticals, Inc. share price today is $41.94
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RIGL is experiencing slight selling pressure.

CVMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.45 Buy
Relative Strength Index (14 RSI): 52.3 Buy
Chaikin Money Flow: -3176 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.49 - 64.93) Buy
Bollinger Bands (100): (62.22 - 64.16) Buy

RIGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.35 Buy
Relative Strength Index (14 RSI): 49.24 Sell
Chaikin Money Flow: -59488 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.15 - 48.01) Sell
Bollinger Bands (100): (28.46 - 42.96) Buy

CVMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.78 Sell
20-day SMA: 63.98 Buy
50-day SMA: 63.51 Buy
200-day SMA: 60.67 Buy
8-day EMA: 64.66 Sell
20-day EMA: 64.22 Buy
50-day EMA: 63.67 Buy
200-day EMA: 61.72 Buy

RIGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.03 Sell
20-day SMA: 45.2 Sell
50-day SMA: 37.61 Buy
200-day SMA: 27.44 Buy
8-day EMA: 9.32 Buy
20-day EMA: 3.99 Buy
50-day EMA: 1.64 Buy
200-day EMA: 0.42 Buy

Calvert US Mid-Cap Core Responsible Index ETF Earnings Growth & CVMC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.

Calvert US Mid-Cap Core Responsible Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rigel Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):